Preparing your experience, please wait…
K
Clinical reviews
MYOCARDITIS AFTER BNT162B2 VACCINATION IN ISRAELI ADOLESCENTS
Rabin Medical Center, Clalit Health Services, Petah Tikva, Israel
PDF20222 pages370 KB
The study highlights that myocarditis cases were predominantly observed in males aged 16 to 29 years after receiving the BNT162b2 vaccine. It reports a mild clinical course for the majority of cases, with most patients remaining hemodynamically stable. The findings suggest that while myocarditis is a rare adverse event, it appears to have a favorable long-term prognosis following vaccination. The correspondence aims to provide further evidence regarding the incidence and follow-up of myocarditis cases in adolescents post-vaccination.
No account needed
Discuss clinical evidence & guidelines
Examine in Ask OslerAsk this resource
Answers from this document onlyMore like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
RESISTANT HYPERTENSION: EPIDEMIOLOGY, MECHANISMS AND CONTEMPORARY THERAPEUTIC STRATEGIES
Same clinical topic · Cardiology
OPTIMAL DIURETIC STRATEGIES IN HEART FAILURE
Same clinical topic · Cardiology
ARRHYTHMIC SYNCOPE: FROM DIAGNOSIS TO MANAGEMENT
Same clinical topic · Cardiology
CORONARY ARTERY CALCIUM IN ACC/AHA PREVENTION GUIDELINES
Same clinical topic · Cardiology
MOBITZ TYPE II SECOND-DEGREE ATRIOVENTRICULAR BLOCK: A COMMONLY OVERDIAGNOSED AND MISINTERPRETED ARRHYTHMIA
Same clinical topic · Cardiology
DIURETIC TREATMENT IN HEART FAILURE
Same clinical topic · Cardiology
PULSED FIELD ABLATION VS STANDARD RADIOFREQUENCY ABLATION FOR TYPICAL ATRIAL FLUTTER
Same clinical topic · Cardiology
PHARMACOTHERAPY OF HEART FAILURE A.D. 2023
Same clinical topic · Cardiology
BEYOND THE 4 PILLARS
Same clinical topic · Cardiology